Skip to Main Content

Eric N. Lindblom

Eric N. Lindblom, JD, is a Senior Scholar and formerly the Director for Tobacco Control and Food and Drug Law at the O’Neill Institute for National and Global Health Law. Mr. Lindblom works on both domestic and international tobacco control matters and also brings his legal, economic, and policy expertise to bear on projects relating to the public health regulation of other products, such as foods, legalized cannabis, alcohol, soda and other beverages, and medical drugs.

Among other projects, Mr. Lindblom works with tobacco control and other regulatory and public health researchers to help make their research more policy relevant and influential by providing the legal and policy contexts for their research and in related proposals, project designs, and publications.

Before joining the O’Neill Institute on a special detail from the FDA Center for Tobacco Products to work on a range of projects relating to the authorities and activities of the FDA Center for Tobacco Products and the regulatory process, Mr. Lindblom was a Senior Advisor to the Director of the Center for Tobacco Products and the Director of the Center’s Office of Policy, where he began serving in January 2011. In this role, Mr. Lindblom worked on the full range of FDA tobacco control activities, with a special focus on legal, policy and economic analyses of existing and proposed CTP initiatives. Under his leadership, the CTP Office of Policy also did extensive liaison work with both the tobacco industry and with U.S. and international tobacco control and public health researchers, other experts, government agencies and non-governmental organizations.

Prior to joining CTP, Mr. Lindblom served as the Director for Policy Research and General Counsel for the Campaign for Tobacco-Free Kids, where he worked since 1998. While with TFK, Mr. Lindblom focused on legal and economic tobacco control issues, and also served as the only public health representative on the USDA Federal trade advisory committee for tobacco and other commodities. Mr. Lindblom was the author of major TFK reports on the multinational cigarette companies’ involvement in the global illicit tobacco products trade and on the major U.S. cigarette companies betrayal of U.S. tobacco farmers, and also wrote or helped draft numerous other TFK reports, legal briefs, white papers, and fact sheets.

Before beginning his work on tobacco control matters, Mr. Lindblom was a public policy analyst and writer for more than ten years, with positions in the federal government, on political campaigns, and with nonprofit organizations. He also worked as a lawyer, both in a private firm and for a nonprofit advocacy organization, was a state-level lobbyist, and served as a legislative assistant to a member of Congress. While working for the U.S. Department of Veterans Affairs from 1990 to 1994, Mr. Lindblom was the author of two interagency reports on homelessness in the United States and the federal government’s efforts to address the problem. Mr. Lindblom has a J.D. from Harvard Law School and a B.A. in Political Science from Yale University.

Featured Publications

Lindblom, Eric N. “How FDA Could Use Its Existing Authorities to Make State Legalization of Cannabis More Safe and Effective.” Food & Drug Law Journal 74, no. 2 (April 2019).
Lindblom, Eric N. “Should FDA Try to Move Smokers to E-Cigarettes and Other Less-Harmful Tobacco Products and, If So, How?” Food & Drug Law Journal 73, no. 2 (May 31, 2018): 276–318.
Lindblom, Eric N. “Are There Any Ethical Barriers to Effective Antismoking Measures.” AJPH 107, no. 9 (September 2017): 1364–65.
Lindblom, Eric N. “How Might Manufacturers of E-Cigarettes Get New Product and MRTP Orders from FDA More Quickly and Easily?” Food & Drug Law Journal, Posted with consent from the Food & Drug Law Journal and the Food & Drug Law Institute, 73, no. 4 (December 2018): 624–41.
Lindblom, Eric N. “Filling in the Blanks on Reducing Tobacco Product Addictiveness in the FCTC Partial Guidelines for Articles 9 & 10.” O’Neill Institute Working Paper No. 1, November 17, 2014.

View all Publications